157 related articles for article (PubMed ID: 18940664)
21. 22-Alkyl-20-epi-1alpha,25-dihydroxyvitamin D3 compounds of superagonistic activity: syntheses, biological activities and interaction with the receptor.
Yamamoto K; Inaba Y; Yoshimoto N; Choi M; DeLuca HF; Yamada S
J Med Chem; 2007 Mar; 50(5):932-9. PubMed ID: 17298045
[TBL] [Abstract][Full Text] [Related]
22. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
[TBL] [Abstract][Full Text] [Related]
23. The difference between 14-epi-previtamin D3 and 14-epi-19-norprevitamin D3: their synthesis and binding affinity for human VDR.
Sawada D; Katayama T; Tsukuda Y; Saito N; Saito H; Kakuda S; Takimoto-Kamimura M; Takenouchi K; Kittaka A
Anticancer Res; 2012 Jan; 32(1):319-26. PubMed ID: 22213322
[TBL] [Abstract][Full Text] [Related]
24. Corepressor excess shifts the two-side chain vitamin D analog Gemini from an agonist to an inverse agonist of the vitamin D receptor.
Gonzalez MM; Samenfeld P; Peräkylä M; Carlberg C
Mol Endocrinol; 2003 Oct; 17(10):2028-38. PubMed ID: 12843209
[TBL] [Abstract][Full Text] [Related]
25. Regulation of parathyroid hypertensive factor secretion by vitamin D3 analogs in parathyroid cells derived from spontaneously hypertensive rats.
Sutherland SK; Nemere I; Benishin CG
J Cell Biochem; 2005 Sep; 96(1):97-108. PubMed ID: 15988762
[TBL] [Abstract][Full Text] [Related]
26. A structural basis for the species-specific antagonism of 26,23-lactones on vitamin D signaling.
Peräkylä M; Molnár F; Carlberg C
Chem Biol; 2004 Aug; 11(8):1147-56. PubMed ID: 15324816
[TBL] [Abstract][Full Text] [Related]
27. New analogs of 2-methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 with conformationally restricted side chains: evaluation of biological activity and structural determination of VDR-bound conformations.
Vanhooke JL; Tadi BP; Benning MM; Plum LA; DeLuca HF
Arch Biochem Biophys; 2007 Apr; 460(2):161-5. PubMed ID: 17227670
[TBL] [Abstract][Full Text] [Related]
28. Side-chain modified vitamin D analogs induce rapid accumulation of VDR in the cell nuclei proportionately to their differentiation-inducing potential.
Gocek E; Kiełbiński M; Wyłób P; Kutner A; Marcinkowska E
Steroids; 2008 Dec; 73(14):1359-66. PubMed ID: 18644400
[TBL] [Abstract][Full Text] [Related]
29. Antileukemic effect of a synthetic vitamin D3 analog, HY-11, with low potential to cause hypercalcemia.
Yoon JS; Kim JY; Park HK; Kim ES; Ahn KS; Yoon SS; Cho CG; Kim BK; Lee YY
Int J Oncol; 2008 Feb; 32(2):387-96. PubMed ID: 18202761
[TBL] [Abstract][Full Text] [Related]
30. Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes.
Pendás-Franco N; Aguilera O; Pereira F; González-Sancho JM; Muñoz A
Anticancer Res; 2008; 28(5A):2613-23. PubMed ID: 19035286
[TBL] [Abstract][Full Text] [Related]
31. Crystal structure of the vitamin D nuclear receptor ligand binding domain in complex with a locked side chain analog of calcitriol.
Rochel N; Hourai S; Pérez-García X; Rumbo A; Mourino A; Moras D
Arch Biochem Biophys; 2007 Apr; 460(2):172-6. PubMed ID: 17346665
[TBL] [Abstract][Full Text] [Related]
32. Involvement of Vitamin D receptor in the intestinal induction of human ABCB1.
Tachibana S; Yoshinari K; Chikada T; Toriyabe T; Nagata K; Yamazoe Y
Drug Metab Dispos; 2009 Aug; 37(8):1604-10. PubMed ID: 19460946
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of 1alpha,25-dihydroxyvitamin D3-26,23-lactams (DLAMs), a novel series of 1 alpha,25-dihydroxyvitamin D3 antagonist.
Kato Y; Nakano Y; Sano H; Tanatani A; Kobayashi H; Shimazawa R; Koshino H; Hashimoto Y; Nagasawa K
Bioorg Med Chem Lett; 2004 May; 14(10):2579-83. PubMed ID: 15109656
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D receptor signaling and its therapeutic implications: Genome-wide and structural view.
Carlberg C; Molnár F
Can J Physiol Pharmacol; 2015 May; 93(5):311-8. PubMed ID: 25741777
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological activities of 14-epi-MART-10 and 14-epi-MART-11: implications for cancer and osteoporosis treatment.
Kittaka A; Hara H; Takano M; Sawada D; Arai MA; Takagi K; Chida T; Harada Y; Saito H; Takenouchi K; Ishizuka S; Hayashi K; Ikushiro S; Sakaki T; Sugiura T; Chen TC
Anticancer Res; 2009 Sep; 29(9):3563-9. PubMed ID: 19667149
[TBL] [Abstract][Full Text] [Related]
36. Structure-activity relationships of 19-norvitamin D analogs having a fluoroethylidene group at the C-2 position.
Kobayashi E; Shimazaki M; Miyamoto Y; Masuno H; Yamamoto K; DeLuca HF; Yamada S; Shimizu M
Bioorg Med Chem; 2007 Feb; 15(3):1475-82. PubMed ID: 17110116
[TBL] [Abstract][Full Text] [Related]
37. A role of helix 12 of the vitamin D receptor in SMRT corepressor interaction.
Kim JY; Son YL; Lee YC
Biochem Biophys Res Commun; 2009 Feb; 379(3):780-4. PubMed ID: 19133230
[TBL] [Abstract][Full Text] [Related]
38. Structure-based design of a superagonist ligand for the vitamin D nuclear receptor.
Hourai S; Rodrigues LC; Antony P; Reina-San-Martin B; Ciesielski F; Magnier BC; Schoonjans K; Mouriño A; Rochel N; Moras D
Chem Biol; 2008 Apr; 15(4):383-92. PubMed ID: 18420145
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of 2alpha-substituted-14-epi-previtamin D3 and its genomic activity.
Sawada D; Katayama T; Tsukuda Y; Saito N; Takano M; Saito H; Takagi K; Ochiai E; Ishizuka S; Takenouchi K; Kittaka A
Bioorg Med Chem Lett; 2009 Sep; 19(18):5397-400. PubMed ID: 19692243
[TBL] [Abstract][Full Text] [Related]
40. Structural investigation of the ligand binding domain of the zebrafish VDR in complexes with 1alpha,25(OH)2D3 and Gemini: purification, crystallization and preliminary X-ray diffraction analysis.
Ciesielski F; Rochel N; Mitschler A; Kouzmenko A; Moras D
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):55-9. PubMed ID: 15225747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]